DKMA Update October 2017

10 October 2017

In this issue of DKMA Update, you can read about the decision to change the dispensing status of a number of opioids, about the new guidelines on medicinal cannabis for doctors, and about the executive order on the import of cannabis products.

This newsletter features the following articles:

  • T cells – new perspectives in cancer treatment
  • More opioids subject to stricter monitoring (dispensing status A§4)
  • Medicinal cannabis – new products, new rules and new guidelines
  • New 9-valent HPV vaccine in the childhood immunisation programme
  • The DKMA is expanding and recruiting new employees
  • New report on biological medicines and biosimilars
  • Global operation against illegal medicines
  • Most recent Direct Healthcare Professional Communications (DHPCs)

Link

DKMA Update, October 2017 (PDF)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.